$VICR

VINCIARELLI PATRIZIO sold $6.6M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $330.56 ($322.74–$342.51, $6.61M total) across 15 trades on 2026-06-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 29, 2026, 2:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 29, 2026, 3:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure provides a concrete, time-stamped insider selling datapoint (size, price range, and post-transaction holdings) but no accompanying fundamental catalyst.

02

Market read

Traders may monitor for follow-on insider activity or interpret the sale as routine 10b5-1 liquidity; absent other news, impact is likely modest.

03

What to watch

The article does not state whether the insider’s remaining stake is changing materially over time, nor does it provide context on prior 10b5-1 sales cadence.

Relevance 5/10Novelty 6/10Timing: today’s SEC Form 4 filing (filed 2026-06-29)

Background

The article is an SEC Form 4 insider transaction: CEO/Chairman VINCIARELLI PATRIZIO sold 20,000 VICR shares across 15 trades on 2026-06-25 under a 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold about $6.61M of shares via a pre-arranged 10b5-1 plan, with weighted-average sale price ~$330.56.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a Form 4 primary disclosure with sale size and pricing, but it does not include new operating, guidance, or regulatory information.

Market effects

No sector read-across is provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the signal may be overstated; traders may treat it as routine liquidity rather than bearish information.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale; CEO/Chairman sold shares under a 10b5-1 plan.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the open-market sale.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: